Aromasin 25 mg tablets contain exemestane, a potent aromatase inhibitor. Designed for postmenopausal women with estrogen-receptor positive breast cancer. Helps reduce estrogen levels to slow cancer growth./Description: Aromasin (exemestane) 25 mg tablets are prescribed for postmenopausal women with estrogen-receptor positive early or advanced breast cancer. By inhibiting the aromatase enzyme, Aromasin effectively reduces estrogen production, which is essential for the growth of certain breast cancers. This targeted approach aids in slowing disease progression and is especially beneficial for patients transitioning from prior tamoxifen therapy. The tablets are round, biconvex, and off-white, marked with "7663" on one side, ensuring easy identification. Manufactured by Pfizer, a trusted name in pharmaceuticals, Aromasin offers a reliable option in breast cancer treatment.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
